Clinical trial
Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00053300 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00053300 |
|---|---|
| Title | Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | Phase II Trial of Daily Thalidomide in Extensive Stage Small Cell Lung Cancer Patients Achieving a Complete or Partial Response to Induction Chemotherapy |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | thalidomide, adjuvant therapy |
| Enrollment | 30 |
| Start date | Aug 1, 2002 |
| Primary completion | Nov 1, 2005 |
| Completion | Apr 1, 2010 |
| First posted | Jan 28, 2003 |
| Last update posted | Jun 10, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: